COMMUNIQUÉS West-GlobeNewswire

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07/04/2026
HIGH POINT, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
07/04/2026
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 07 avr. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
07/04/2026
CONSHOHOCKEN, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Monthly information on share capital and company voting rights
07/04/2026
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, April 07, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
Natural Remedies Awarded American Botanical Council’s 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award
07/04/2026
ANAHEIM, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- American Botanical Council (ABC) presented Natural Remedies with the prestigious 2026 ABC Varro E. Tyler Commercial Investment in Phytomedicinal Research Award during [...]
GENFIT Announces Publication of the 2025 Universal Registration Document
07/04/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 07, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
IBA – ACQUISITION D’ACTIONS PROPRES
07/04/2026
Louvain-la-Neuve, Belgique, 7 avril 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application
07/04/2026
~ Approval Marks Satisfaction of Key Closing Condition in Pending Merger ~ WEXFORD, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen [...]
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
07/04/2026
BURLINGTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, [...]
IBA – ACQUISITION OF OWN SHARES
07/04/2026
Louvain-la-Neuve, Belgium, April 7 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
Gluco Zen Drops Under Investigation: Safety Concerns Arise Amid Researching the Ingredients' Side Effects Risk for GlucoZen
07/04/2026
A 2026 informational overview addressing common consumer research topics including GlucoZen Drops side effects, ingredient dosage transparency, blood sugar supplement safety considerations, refund and return policy [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
07/04/2026
Nantes, le 7 avril 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
07/04/2026
Déclaration de transactions sur actions propres Paris, France (7 avril 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que du 1 er avril 2026 au [...]
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025
07/04/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 07 avril 2026 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies [...]
EssilorLuxottica: Disclosure of transactions in own shares
07/04/2026
Disclosure of transactions in own shares Paris, France (April 7, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that from [...]
Folia Health Launches App-Based Study to Unlock Novel Real-World Evidence of Symptom Burden and Unmet Need for Patients and Caregivers in CIDP
07/04/2026
BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Folia Health today announced a collaboration with argenx to launch a first-of-its-kind, at-home observational real-world evidence initiative supporting individuals living with [...]
BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform
07/04/2026
Collaboration builds on CAR-T commercialization in New Zealand and supports expansion across Australia, North America and other international markets WELLINGTON, New Zealand and KINGSTON, Ontario, April 07, 2026 (GLOBE [...]
Regional Health Properties Reports Fourth Quarter 2025 Results
07/04/2026
Reported Full Year Profitability of $3.4 million Repurchased 511,099 Series B Preferred Shares HealthCare Services segment reports 20% growth in Average Daily Census ATLANTA, GA, April 07, 2026 (GLOBE NEWSWIRE) -- [...]
HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification
07/04/2026
Rigorous training and certification gives clinicians a validated pathway to AI-enabled cardiac POCUS proficiency ROCKVILLE, Md. and BORDEAUX, France, April 07, 2026 (GLOBE NEWSWIRE) -- HeartFocus , the AI-enabled [...]

Pages